Compositions comprising a nutritionally or pharmaceutically effective dosage of an extract of Salvia officinalis and an acceptable carrier are provided. The compositions show particular potential in the treatment of age-related pathologies in humans or animals.

March 19, 2024 - We cannot provide a description for this page right now

Summary Chronos Therapeutics Ltd Chronos is a research company that offers drug discovery and development services. The company offers research and development, drug discovery, lead optimization, preclinical efficacy, IND enabling, screening, ...

You need to enable JavaScript to run this app

You need to enable JavaScript to run this app

The companies will work together on integrated drug discovery - medicinal and computational chemistry, biology and DMPK - to optimise Chronos’ selective orexin 1 antagonists that have shown promise in treating addiction.

Chrono Therapeutics is a pharmaceutical company with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery that offers real-time behavioral support. Chrono’s executive leadership combines years of professional ...

CHRONOS THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity

Chronos Therapeutics Limited operates as a pharmaceutical company. The Company discovers and develops chronos therapeutics drugs for neurodegenerative diseases.

Chronos Therapeutics is a drug development company focused on the development of drugs for the treatment of age-related diseases.

Chronos Therapeutics drug development scheme focuses in two main areas: - Repositioning FDA approved drugs. - Screening, discovery and development of novel proprietary drug candidates.

Chronos Therapeutics is a drug development company focused on the development of drugs for the treatment of age-related diseases.

Innovative membership organization offering services to the international sector. Instant access to high quality CV’s, procurement notices shortlist and awards information

September 9, 2024 - BioWorld Content on 'Chronos Therapeutics Ltd.'

Chronos is a CNS specialist company with a high concentration of expertise in both degenerative and behavioural diseases of the brain and nervous system. What we do: Chronos is an Oxford-based biotechnology company operating a semi-virtual ...

October 7, 2025 - The five-year survival of the severe grades is 5%. The data generated for SFX-01 in standard preclinical models and orthotopic models (where glioma cells are implanted in brain tissue representing a more disease-relevant model) show tumour shrinkage and significantly extended survival times. SFX-01 was also found to potentiate (i.e. substantially increase) the therapeutic effect of radiotherapy in these models.

Chronos Therapeutics Ltd is a privately held biotechnology company focused on diseases of ageing, brain and nervous system disorders. Chronos has a dedicated laboratory in Oxford which screens for activity of drugs in brain disease through its proprietary platform, ChronoscreenTM.

Developer of therapeutic drugs intended to offer treatment for nervous system disorders. The company's services engage i ... PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies.

The SIC codes for Chronos Therapeutics are [873, 87].

The deal added Chronos's late preclinical-stage assets to TheraCryf's pipeline, including an orexin-1 (Ox-1) antagonist for impulsivity, anxiety, and addiction disorders, and an atypical dopamine transporter (DAT) inhibitor for fatigue and the orphan condition narcolepsy. This strategic move was designed to leverage Chronos's specialization in neuropsychiatry alongside TheraCryf's focus on oncology and neurodevelopmental disorders.